Source:http://linkedlifedata.com/resource/pubmed/id/15790542
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-3-25
|
pubmed:abstractText |
A recent paper by Zong et al. describes how alkylating agents kill cells by a process they term "programmed necrosis," induced by excessive activation of PARP resulting in degradation of cytosolic NAD(+) and inhibition of glycolysis. We argue that it is not obvious whether chemotherapy in patients can induce sufficient NAD(+) loss to affect glycolysis; that the "programmed" nature of the necrosis requires more evidence; and that there are mechanisms making cancer cells hypersensitive to DNA damage other than their high rate of aerobic glycolysis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1368-7646
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15790542-Animals,
pubmed-meshheading:15790542-Apoptosis,
pubmed-meshheading:15790542-DNA Damage,
pubmed-meshheading:15790542-Glycolysis,
pubmed-meshheading:15790542-Humans,
pubmed-meshheading:15790542-NAD,
pubmed-meshheading:15790542-Necrosis,
pubmed-meshheading:15790542-Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
Cancer cell death by programmed necrosis?
|
pubmed:affiliation |
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|